Heather Zore
Family · Indianapolis, INNPI 1255956272
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Johnson & Johnson at 29.9% of the total. Reporting peaked in 2021 at $836 and has fallen 67.6% since, to $271 in 2025.
Across 187 payments — averaging $14.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$791
- Bausch Health US, LLC$309
- AbbVie$269
- Takeda Pharmaceuticals U.S.A., Inc.$173
- Otsuka America Pharmaceutical, Inc.$115
- Adlon Therapeutics L.p.$113
- plus $877 from 18 others
What the payments were for
- Food & beverage$2,647100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 59 | $791 |
| Bausch Health US, LLC | 43 | $309 |
| AbbVie | 14 | $269 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $173 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| Adlon Therapeutics L.p. | 11 | $113 |
| Vanda Pharmaceuticals Inc. | 4 | $108 |
| Ironshore Pharmaceuticals Inc. | 6 | $105 |
| Neos Therapeutics, LP | 6 | $105 |
| Noven Therapeutics, LLC | 4 | $73 |
| Corium, LLC | 4 | $64 |
| Eisai Inc. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 2 | $57 |
| Supernus Pharmaceuticals, Inc. | 1 | $48 |
| Lundbeck LLC | 3 | $46 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| OWP Pharmaceuticals, Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Alkermes, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Merck | 1 | $14 |
How this compares
$2,647 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.
Other family in Indianapolis
- Tina SizemoreIndianapolis$888K
- Marla MosesIndianapolis$142K
- Leslye FisherIndianapolis$73K
- Alicia WettrickIndianapolis$72K
- Christine BaltIndianapolis$30K
- Kathryn KennedyIndianapolis$29K
- Andrea RandallIndianapolis$27K
- Deidre ArmsIndianapolis$26K
- Carrie GravesIndianapolis$16K
- Dominique LevequeIndianapolis$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.